脊髓爆发刺激与安慰剂刺激对腰椎术后慢性根性疼痛患者功能障碍的影响:一项随机临床试验
这项安慰剂对照交叉随机临床试验在挪威圣奥拉夫斯大学医院纳入50例腰椎退行性疾病术后慢性根性疼痛患者,比较脊髓爆发刺激与安慰剂刺激各两个3个月期的效果。主要结局Oswestry功能障碍指数(ODI)变化在两组间差异无统计学意义(-1.3分,95%CI -3.9至1.3,P=0.32),预设次要结局均无显著差异,9例(18%)发生不良事件,其中4例(8%)需手术修正植入系统。
要点
- 脊髓爆发刺激与安慰剂刺激相比,ODI评分变化差异无统计学意义(-1.3分,95%CI -3.9至1.3,P=0.32)。
- 预设次要结局(腿痛、背痛、生活质量、体力活动水平)均无显著差异。
- 9例(18%)发生不良事件,其中4例(8%)需手术修正植入系统。
核心结论
- 在腰椎术后慢性根性疼痛患者中,放置脊髓刺激器后,脊髓爆发刺激与安慰剂刺激相比,自我报告背痛相关功能障碍自基线的变化无显著差异。
研究设计与样本
- 安慰剂对照、交叉、随机临床试验,在挪威圣奥拉夫斯大学医院开展,纳入50例腰椎退行性疾病术后慢性根性疼痛患者。
- 入组时间为2018年9月5日至2021年4月28日,末次随访日期为2022年5月20日。
- 患者按随机顺序接受两个3个月期的脊髓爆发刺激和两个3个月期的安慰剂刺激。
- 爆发刺激为紧密间隔的高频电刺激,采用40 Hz爆发模式恒流刺激,每爆发4个棘波,幅度为感觉异常感知阈值的50%至70%。
主要发现
- 50例随机患者平均年龄52.2岁(SD 9.9),27例(54%)为女性;47例(94%)至少有一次随访ODI评分,42例(84%)完成所有刺激随机期和ODI测量。
- 基线ODI平均评分44.7分;爆发刺激期ODI平均变化-10.6分,安慰剂刺激期-9.3分,组间平均差异-1.3分(95%CI -3.9至1.3,P=0.32)。
- 预设次要结局均未显示显著差异。
- 9例(18%)发生不良事件,其中4例(8%)需手术修正植入系统。
关键数值与推荐
- 主要结局为Oswestry功能障碍指数(ODI;范围0分[无功能障碍]至100分[最大功能障碍];最小临床重要差异为10分)自基线变化在爆发刺激期与安慰剂刺激期之间的差异。
- 次要结局为腿痛、背痛、生活质量、体力活动水平和不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The use of spinal cord stimulation for chronic pain after lumbar spine surgery is increasing, yet rigorous evidence of its efficacy is lacking. OBJECTIVE: To investigate the efficacy of spinal cord burst stimulation, which involves the placement of an implantable pulse generator connected to electrodes with leads that travel into the epidural space posterior to the spinal cord dorsal columns, in patients with chronic radiculopathy after surgery for degenerative lumbar spine disorders. DESIGN, SETTING, AND PARTICIPANTS: This placebo-controlled, crossover, randomized clinical trial in 50 patients was conducted at St Olavs University Hospital in Norway, with study enrollment from September 5, 2018, through April 28, 2021. The date of final follow-up was May 20, 2022. INTERVENTIONS: Patients underwent two 3-month periods with spinal cord burst stimulation and two 3-month periods with placebo stimulation in a randomized order. Burst stimulation consisted of closely spaced, high-frequency electrical stimuli delivered to the spinal cord. The stimulus consisted of a 40-Hz burst mode of constant-current stimuli with 4 spikes per burst and an amplitude corresponding to 50% to 70% of the paresthesia perception threshold. MAIN OUTCOMES AND MEASURES: The primary outcome was difference in change from baseline in the self-reported Oswestry Disability Index (ODI; range, 0 points [no disability] to 100 points [maximum disability]; the minimal clinically important difference was 10 points) score between periods with burst stimulation and placebo stimulation. The secondary outcomes were leg and back pain, quality of life, physical activity levels, and adverse events. RESULTS: Among 50 patients who were randomized (mean age, 52.2 [SD, 9.9] years; 27 [54%] were women), 47 (94%) had at least 1 follow-up ODI score and 42 (84%) completed all stimulation randomization periods and ODI measurements. The mean ODI score at baseline was 44.7 points and the mean changes in ODI score were -10.6 points for the burst stimulation periods and -9.3 points for the placebo stimulation periods, resulting in a mean between-group difference of -1.3 points (95% CI, -3.9 to 1.3 points; P = .32). None of the prespecified secondary outcomes showed a significant difference. Nine patients (18%) experienced adverse events, including 4 (8%) who required surgical revision of the implanted system. CONCLUSIONS AND RELEVANCE: Among patients with chronic radicular pain after lumbar spine surgery, spinal cord burst stimulation, compared with placebo stimulation, after placement of a spinal cord stimulator resulted in no significant difference in the change from baseline in self-reported back pain-related disability. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03546738.
引用
- Hara S, Andresen H, Solheim O, et al. Effect of Spinal Cord Burst Stimulation vs Placebo Stimulation on Disability in Patients With Chronic Radicular Pain After Lumbar Spine Surgery: A Randomized Clinical Trial. JAMA. 2022. PMID: 36255427. doi:10.1001/jama.2022.18231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。